Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial
Background. Research has shown less aggressive treatment and poorer control of cardiovascular disease (CVD) risk factors in women than men. Methods. We analyzed sex differences in pharmacotherapy strategies and attainment of goals for hemoglobin A1c (HbA1c), blood pressure (BP), and low density lipo...
Main Authors: | Michelle F. Magee, Jacqueline E. Tamis-Holland, Jiang Lu, Vera A. Bittner, Maria Mori Brooks, Neuza Lopes, Alice K. Jacobs, BARI 2D Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2015/610239 |
Similar Items
-
Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
by: Safi U. Khan, et al.
Published: (2020-03-01) -
LDL-cholesterol targets as Achilles’ heel of 2020 ISH guidelines
by: Krzysztof J. Filipiak
Published: (2021-03-01) -
Erratum to “Cardiovascular Mortality after Intensive LDL-Cholesterol Lowering: Does Baseline LDL-Cholesterol Really Matter?” [American Journal of Preventive Cardiology 1C (2020) 100013]
by: Safi U. Khan, et al.
Published: (2021-03-01) -
Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathwayss⃞
by: Ming-Dong Wang, et al.
Published: (2007-03-01) -
Targeting LDL Cholesterol With LNA
by: Arthur M Krieg
Published: (2012-01-01)